D-0654-2026 Class III Ongoing

Recalled by SUN PHARMACEUTICAL INDUSTRIES INC — Princeton, NJ

FDA drug recall D-0654-2026 was initiated by SUN PHARMACEUTICAL INDUSTRIES INC on Jun 1, 2026 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is ongoing. Affected quantity: 9,048 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2026
Initiation Date
Jun 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9,048 bottles

Product description

Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

U.S. Nationwide

Code information

Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0654-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0654-2026. Report a data issue: hello@regdatalab.com.